Raloxifene increases serum leptin levels in postmenopausal women: a prospective study.

Cakmak A., Posaci C., Dogan E., Caliskan S., Guclu S., ALTUNYURT S.

American journal of obstetrics and gynecology, vol.193, no.2, pp.347-51, 2005 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 193 Issue: 2
  • Publication Date: 2005
  • Doi Number: 10.1016/j.ajog.2005.01.023
  • Journal Name: American journal of obstetrics and gynecology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.347-51
  • Keywords: raloxifene, leptin, insulin-like growth factor-I, biochemical markers, BONE-MINERAL DENSITY, GROWTH-FACTOR-I, HORMONE REPLACEMENT THERAPY, IGF-I, BREAST-CANCER, INSULIN, MENOPAUSE, OSTEOPOROSIS, MASS, HRT
  • Dokuz Eylül University Affiliated: Yes

Abstract

Objective: The purpose of this study was to investigate the effect of raloxifene on leptin and insulin-like growth factor-I levels and their relation with the biochemical markers of bone metabolism in postmenopausal women.